- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non-alcoholic Fatty Liver Disease NAFLD in United Kingdom
Total 797 results
-
Duke UniversityUniversity of FloridaTerminatedInsulin Resistance | Nonalcoholic Fatty Liver DiseaseUnited States
-
Bristol-Myers SquibbCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis | Liver Fibrosis | Hepatic CirrhosisUnited States
-
Henry M. Jackson Foundation for the Advancement...Infectious Diseases Clinical Research ProgramCompletedCoronary Artery Disease | HIV Infections | Non-Alcoholic Fatty Liver DiseaseUnited States
-
89bio, Inc.CompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Gilead SciencesCompletedNonalcoholic SteatohepatitisHong Kong, United States, Australia, Puerto Rico, New Zealand, Canada
-
National Cancer Institute (NCI)RecruitingHepatocellular Carcinoma | Nonalcoholic SteatohepatitisUnited States
-
Arkansas Children's Hospital Research InstituteNational Institute of General Medical Sciences (NIGMS)CompletedHigh Intensity Interval Training | Insulin Resistance | Childhood Obesity | Non-Alcoholic Fatty Liver DiseaseUnited States
-
National Institute of Diabetes and Digestive and...Completed
-
PfizerCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Israel, Taiwan, Canada, Australia, Poland
-
Tobira Therapeutics, Inc.TerminatedLiver Cirrhosis | Non-alcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Australia, France, Germany, Spain, Poland, United Kingdom, Italy, Puerto Rico, Belgium, Hong Kong
-
Gilead SciencesNovo Nordisk A/SActive, not recruitingNonalcoholic SteatohepatitisUnited States, Spain, Australia, France, Japan, Puerto Rico, Canada
-
University of Missouri-ColumbiaWithdrawnType 2 Diabetes | Non-alcoholic Fatty Liver DiseaseUnited States
-
VA Office of Research and DevelopmentTerminated
-
Brown UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcoholic Liver Disease | Alcoholism,United States
-
Galectin Therapeutics Inc.CompletedNonalcoholic SteatohepatitisUnited States
-
HistogenCompletedCirrhosis | Portal Hypertension | Non-alcoholic SteatohepatitisUnited States, Germany, Spain
-
AstraZenecaQuotient SciencesCompletedChronic Kidney Disease | Type 2 Diabetes Mellitus (T2DM) | Non-alcoholic SteatohepatitisUnited Kingdom
-
NGM Biopharmaceuticals, IncCompletedNonalcoholic Steatohepatitis | Compensated CirrhosisUnited States, Australia, Belgium, France, Germany, Hong Kong, Poland, Puerto Rico, United Kingdom
-
Aligos TherapeuticsActive, not recruitingNonalcoholic Steatohepatitis | NASH | MASH | Metabolic Dysfunction-Associated SteatohepatitisUnited States
-
VA Office of Research and DevelopmentCompletedNonalcoholic SteatohepatitisUnited States
-
University of California, San DiegoRecruitingNonalcoholic Steatohepatitis | Nonalcoholic Fatty Liver | Liver Inflammation | Liver FibrosesUnited States
-
University of MichiganCompletedNAFLD | Nonalcoholic Steatohepatitis | Familial Partial LipodystrophyUnited States
-
Tobira Therapeutics, Inc.CompletedNonalcoholic SteatohepatitisBelgium, Spain, Hong Kong, United States, France, Germany, Australia, United Kingdom, Poland, Italy
-
King's College Hospital NHS TrustSamsung MedisonRecruitingHepatitis | Liver Fat | NAFLD | Fibrosis, Liver | Liver Disease Chronic | Liver Steatoses | NASH With FibrosisUnited Kingdom
-
Massachusetts General HospitalTerminatedHBV | Chronic Liver Disease | HCV Coinfection | Non-Alcoholic Fatty Liver Disease | Drug-Induced Liver InjuryUnited States
-
University of OklahomaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingObesity | Nonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverUnited States
-
National Institute of Allergy and Infectious Diseases...The University of Texas Health Science Center, HoustonCompletedHIV Infections | Non-Alcoholic Fatty Liver DiseaseUnited States, Brazil
-
PerspectumRecruitingLiver Diseases | Cirrhosis | Primary Sclerosing Cholangitis | Autoimmune Hepatitis | Hemochromatosis | Non-Alcoholic Fatty Liver Disease | Non-Alcoholic Steatohepatitis | Primary Biliary Cirrhosis | Viral HepatitisNetherlands, United Kingdom
-
NGM Biopharmaceuticals, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
Massachusetts General HospitalNational Institutes of Health (NIH)WithdrawnNon-alcoholic Fatty Liver DiseaseUnited States
-
Massachusetts General HospitalNational Institute of Allergy and Infectious Diseases (NIAID)CompletedNonalcoholic Steatohepatitis (NASH) | Human Immunodeficiency Virus (HIV) | Nonalcoholic Fatty Liver Disease (NAFLD)United States
-
Columbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Albert...Not yet recruitingInsulin Resistance | Prediabetic State | Overweight and Obesity | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Madrigal Pharmaceuticals, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Spain, Australia, United Kingdom, Canada, Israel, Belgium, Italy, France, Puerto Rico, Switzerland, Germany, Austria, Poland, Mexico, Hungary
-
Akero Therapeutics, IncActive, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Mexico, Puerto Rico
-
University of California, San DiegoRecruitingType 2 Diabetes Mellitus in Obese | Fibrosis, Liver | Non-Alcoholic Fatty Liver DiseaseUnited States
-
89bio, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
George Washington UniversityCompletedPsoriasis | Nonalcoholic Fatty Liver DiseaseUnited States
-
Redx Pharma PlcSimbec ResearchCompletedLiver Diseases | Fibrosis | Kidney Diseases | Inflammation | Idiopathic Pulmonary Fibrosis | Non-alcoholic SteatohepatitisUnited Kingdom
-
Columbia UniversityUniversity of California, BerkeleyRecruitingInsulin Resistance | Prediabetic State | Overweight and Obesity | Non-Alcoholic Fatty Liver DiseaseUnited States
-
AstraZenecaAstraZeneca K.K.Active, not recruitingNonalcoholic SteatohepatitisUnited States, Italy, Thailand, Germany, Korea, Republic of, Turkey, Vietnam, China, Malaysia, Taiwan, Hong Kong, Chile, Spain, Japan, Mexico, Brazil, Argentina, India, Singapore, Philippines, Peru, Colombia
-
Zydus Therapeutics Inc.RecruitingFibrosis | Nonalcoholic SteatohepatitisUnited States, Turkey, Argentina
-
Augusta UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedNon-alcoholic Fatty Liver Disease | Overweight and ObesityUnited States
-
Viking Therapeutics, Inc.CompletedNASH - Nonalcoholic SteatohepatitisUnited States, Belgium, France, Mexico, Puerto Rico
-
Tobira Therapeutics, Inc.TerminatedNonalcoholic SteatohepatitisUnited States, Spain, Australia, Belgium, Israel, Canada, Puerto Rico, Italy, Germany, France, New Zealand, Taiwan, Poland, United Kingdom, Brazil, Austria, Singapore, Portugal, Chile, Greece, Hong Kong, Hungary, Latvia, Mexico, Norway, R... and more
-
Corcept TherapeuticsRecruitingNonalcoholic Steatohepatitis (NASH) | Metabolic Dysfunction-associated Steatohepatitis (MASH)United States, Puerto Rico
-
Terns, Inc.CompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Washington University School of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Virginia Commonwealth UniversityMeridian Bioscience, Inc.TerminatedMetabolic Syndrome | Nonalcoholic Fatty Liver DiseaseUnited States
-
University of NottinghamNational Institute for Health Research, United KingdomCompletedDecompensated Cirrhosis | Alcoholic Liver DiseasesUnited Kingdom
-
US Department of Veterans AffairsTerminatedFatty Liver | Insulin ResistanceUnited States